Managing Wound Infection: Negative Pressure Wound Therapy with Instillation

Regional Meeting

Board Certified Plastic Surgeon
Southeastern Plastic Surgery, P.A.
Tallahassee, Florida

Chairman Emeritus
Division of Trauma Surgery/Surgical Critical Care
Associate Trauma Medical Director and Chief of Trauma
Surgical Critical Care Unit
Trinity Mother Frances Health System
Tyler, Texas

Associate Professor
Georgetown University School of Medicine
Vice Chair of Research
MedStar Plastic & Reconstructive Surgery
MedStar Georgetown University Hospital
Washington, DC

Certified Wound, Ostomy, Continence Nurse
Tower Health
Reading, Pennsylvania

Intended Learners

This activity is designed for surgeons, physicians, podiatrists, nurses, pharmacists, and other allied health professionals involved in the treatment of patients with chronic and complex wounds.

Learning Objectives

After completing this activity, participants should be able to:

• Discuss the impact of biofilms and bacteria on wound healing
• Review the current wound treatment practice for infected wounds
• Recognize the impact of different topical wound treatment solutions on the infected wound

Activity Overview

After successful completion of the post-test and evaluation form online at, participants may immediately print their documentation of credit.

Participants who have successfully completed the live version of this activity are not eligible for credit for this enduring material.

For questions regarding this educational activity, please call 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested (please download here) for video programs. A PDF reader is required for print publications. Please direct technical questions to


 In support of improving patient care, North American Center for Continuing Medical Education (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.



NACCME designates this live material for a maximum of 1.0 AMA PRA Category 1 Credit™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.


This continuing nursing education activity awards 1.0 contact hour.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.00 contact hour.

Continuing Podiatric Education

North American Center for Continuing Medical Education, LCC (NACCME) is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. NACCME has approved this activity for a maximum of 1.0 continuing education contact hour.


This activity is approved for 1 contact hour (0.1 CEU) of continuing pharmacy education UAN JA0006201-0000-18-002-L01-P

This is a knowledge-based activity.

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact the Senior Manager, Accreditation & Compliance, NACCME, in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. The Senior Manager, Accreditation & Compliance will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Senior Director, Accreditation and Compliance, NACCME, may be made for a second level of review.

Planning Committee

The planning committee comprises Chris Derosier, MD, Daniel Federman, MD, FACP, Paul J. Kim, DPM, MS, Luis G. Fernández, MD, KHS, FACS,
FASAS, FCCP, FCCM, FICS, Elizabeth McElroy, CRNP, CWS, CWOCN-AP, Susie Seaman, NP; and Tiffney Oliver, Randy Robbin, Margaret Stefan,
and Susan Yarbrough, NACCME.

Independent clinical reviewer: Daniel Federman, MD, FACP, Professor of Medicine, Yale University School of Medicine, Associate Chief of Medicine,
VA Connecticut Healthcare System, West Haven, Connecticut

Nurse planner: Susie Seaman, NP, Sharp Rees-Stealy Wound Clinic, San Diego, California

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required
to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are
identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve
the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty have reported the following:
Dr. Derosier: Consultant—Acelity
Dr. Fernández: Research/Speaker’s Bureau/Advisor—Acelity
Dr. Kim: Consultant/Speaker’s Bureau—Acelity Inc., Integra LifeSciences
Ms. McElroy: Consultant/Speaker’s Bureau—Acelity
Ms. Seaman: Scientific advisor—Smith & Nephew, Inc.; Mölnlycke Health Care; Promotional Speaker’s Bureau—Smith & Nephew, Inc.

Dr. Federman has disclosed no relevant financial relationships with any commercial interests.

Ms. Oliver, Mr. Robbin, Ms. Stefan, and Ms. Yarbrough have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed that no off-label/unapproved uses of drugs and/or devices will be discussed.

Brand names are included in this presentation for participant clarification purposes only. No product promotion should be inferred.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2017 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

Grant Support

Supported by an educational grant from Acelity™

1.00 CME
1.00 CNE
1.00 CPE
1.00 CPME